Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Neoplasms 3 Thyroid Cancer, Papillary 3 Salivary Gland Neoplasms 3 Head and Neck Neoplasms 3 Gastrointestinal Stromal Tumors 3 Central Nervous System Neoplasms 3 Breast Neoplasms 3 Brain Neoplasms 3 Thyroid Diseases 2 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neuroblastoma 2 Neoplasms by Site 2 Melanoma 2 Medulloblastoma 2 Lung Neoplasms 2 Lung Diseases 2 Glioma 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Bronchogenic 2 Bronchial Neoplasms 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Desmoid Tumors × Sarcoma × Clear all

NCT03785964 2025-01-31

DeFi

SpringWorks Therapeutics, Inc.

Phase 3 Completed

142 enrolled 21 charts 1 FDA

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡